Cargando…
Impact of chemotherapy-induced amenorrhea in breast cancer patients: the evaluation of ovarian function by menstrual history and hormonal levels
BACKGROUND: Chemotherapy-induced amenorrhea (CIA) is one of the most frequent therapy-related adverse events observed in breast cancer patients who have undergone chemotherapy. Although the characteristics of CIA have been studied in Western countries, little is known about CIA in Asian. We conducte...
Autores principales: | Meng, Kexin, Tian, Wei, Zhou, Meiqi, Chen, Hailong, Deng, Yongchuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666994/ https://www.ncbi.nlm.nih.gov/pubmed/23688389 http://dx.doi.org/10.1186/1477-7819-11-101 |
Ejemplares similares
-
Amenorrhea and Menopause in Patients with Breast Cancer after Chemotherapy
por: Shin, Jae Jun, et al.
Publicado: (2019) -
Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study
por: Ünal, Çağlar, et al.
Publicado: (2023) -
Ovarian Ablation Using Goserelin Improves Survival of Premenopausal Patients with Stage II/III Hormone Receptor-Positive Breast Cancer without Chemotherapy-Induced Amenorrhea
por: Zhou, Juan, et al.
Publicado: (2015) -
Prognostic impact of chemotherapy-induced amenorrhea on premenopausal breast cancer: a meta-analysis of the literature
por: Zhou, Qiong, et al.
Publicado: (2015) -
Chemotherapy-induced amenorrhea in patients suffering from breast cancer in the Northwest of Iran
por: Eivazi-Ziaei, Jamal, et al.
Publicado: (2014)